Stress, Stress, Psychological
Conditions
Brief summary
The current study examines an adapted guided self-help stress reduction program, focusing on reducing stress in the time of COVID-19. Two studies are planned: 1) an international study in English in which individuals proficient in English throughout the world will participate and 2) a follow-up study in Hebrew.
Detailed description
The current study examines an adapted guided self-help stress reduction program, focusing on reducing stress in the time of COVID-19. Two studies are proposed: 1) an international study in English in which individuals proficient in English throughout the world will participate and 2) a study in Hebrew. The first study will publicize via social media and participants will be randomized to either immediate participation or a 6 week waitlist period. Assessments will be conducted pre, (again after waitlist for the control group), posttx (after completion/cessation of the program), 6 month and 1 year followup. Two forms of assessment will be conducted: pre-post-follow-up (with the CRISIS measure) and weekly during the program (via the DASS-21). For the full program see: https://www.iterapi.se/sites/coronastress/
Interventions
BEHAVIORALInternet-based guided self-help based on CBT principles
Individuals are provided basic rationale of CBT to deal with stress, worry, anxiety, dysphoria, sleep difficulties, emotion dysregulation, and memories all related to COVID-19
Sponsors
Hebrew University of Jerusalem
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
This is a randomized trial to either immediate or delayed access to the internet guided self-help program
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Read/Write English, * feels stress due to Corona/COVID-19
Exclusion criteria
* current psychological or psychiatric treatment, * current psychiatric illness, * suicidality, * psychosis, * bipolar, * severe dissociative symptoms, * in a currently severe traumatic situation, * having a serious medical illness.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The CoRonavIruS Health Impact Survey (CRISIS) | change from Pre to post treatment (6 weeks), | change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Depression, Anxiety, and Stress Scale- 21 item version: DASS-21 | Weekly change during treatment and at pre and post (6 week) treatment evaluations | a self-report measure of depression, anxiety and stress, with each subscale ranging from 0-28. Higher means more symptomatic. |
Other
| Measure | Time frame | Description |
|---|---|---|
| completion rate of modules | 6 weeks | how many modules each individual completes, with less than 2 being considered dropout |
Countries
Israel
Contacts
Primary ContactJonathan Huppert, PhD
Outcome results
None listed